First Trust Advisors LP Meridian Bioscience Inc Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$23.75 - $31.69 $557,246 - $743,542	-23,463 Reduced 26.19%	66,118 $2.01 Million
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $370,423 - $499,710	18,549 Added 26.11%	89,581 $2.33 Million
Q4 2021 Feb 08, 2022	BUY	$17.46 - $21.61 $153,298 - $189,735	8,780 Added 14.1%	71,032 $1.45 Million
Q3 2021 Nov 15, 2021	BUY	$17.35 - $22.5 $1.08 Million - $1.4 Million	62,252 New	62,252 $1.2 Million
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $2.51 Million - $3.94 Million	-139,157 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$19.76 - $29.89 $442,624 - $669,536	22,400 Added 19.19%	139,157 $3.65 Million
Q4 2020 Feb 02, 2021	BUY	$15.73 - $21.66 $1.84 Million - $2.53 Million	116,757 New	116,757 $2.18 Million
Q3 2020 Nov 05, 2020	SELL	$13.54 - $26.41 $1.16 Million - $2.27 Million	-85,942 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$7.84 - $23.29 $49,321 - $146,517	6,291 Added 7.9%	85,942 $2 Million
Q1 2020 May 06, 2020	SELL	$5.57 - $11.5 $86,045 - $177,652	-15,448 Reduced 16.24%	79,651 $669,000
Q4 2019 Feb 03, 2020	SELL	$7.9 - $10.14 $14,164 - $18,181	-1,793 Reduced 1.85%	95,099 $929,000
Q3 2019 Nov 04, 2019	BUY	$9.17 - $12.01 $888,499 - $1.16 Million	96,892 New	96,892 $920,000
Q3 2018 Oct 25, 2018	SELL	$14.85 - $16.35 $713,676 - $785,764	-48,059 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$13.8 - $16.8 $101,402 - $123,446	7,348 Added 18.05%	48,059 $764,000
Q1 2018 Apr 23, 2018	BUY	$13.8 - $16.2 $40,475 - $47,514	2,933 Added 7.76%	40,711 $578,000
Q4 2017 Feb 08, 2018	BUY	$13.55 - $15.8 $58,237 - $67,908	4,298 Added 12.84%	37,778 $529,000
Q3 2017 Oct 24, 2017	BUY	$13.45 - $14.35 $450,306 - $480,438	33,480	33,480 $479,000

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account